Document:

Form of Additional Investment Right

 EXHIBIT 10.3 
  
 FORM OF ADDITIONAL INVESTMENT RIGHT 
  
 NEITHER THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE
EXERCISABLE HAVE BEEN REGISTERED OR QUALIFIED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF WITHOUT EITHER (I) AN EFFECTIVE REGISTRATION STATEMENT
FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, (II) AN OPINION OF COUNSEL, IN A FORM REASONABLY ACCEPTABLE TO THE ISSUER, THAT SUCH TRANSFER MAY BE MADE WITHOUT REGISTRATION OR QUALIFICATION UNDER SAID ACT OR (III) SUCH TRANSFER
BEING MADE PURSUANT TO RULE 144 UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 
  
 EDIETS.COM, INC. 
  
 ADDITIONAL INVESTMENT RIGHT 
  
 Additional Investment Right No.:
                     
 Number of Shares:
                     
 Date of Issuance: April
    , 2004 (“Issuance Date”) 
  
 eDiets.com, Inc., a Delaware corporation (the “Company”), hereby certifies that, for value received, the receipt and sufficiency of which are hereby acknowledged,
                                     or its permitted
assigns (the “Holder”), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, at any time or times on or after the date hereof, but not after 11:59
p.m., New York City time, on the Expiration Date (as defined below),                     
(                    )1 fully paid nonassessable shares of Common Stock (as defined below) (the “Additional Investment Right Shares”). Except as otherwise defined herein, capitalized terms in this Additional Investment Right shall have the
meanings set forth in Section 15. This Additional Investment Right (including all Additional Investment Rights issued in exchange, transfer or replacement hereof, the “Additional 

	1	Insert number equal to 25% of the Common Shares purchased by the Holder on the Closing Date. 

 Investment Rights”) is one of the Additional Investment Rights (the “SPA Additional Investment
Rights”) issued pursuant to Section 1 of that certain Securities Purchase Agreement, dated as of April 12, 2004 (the “Initial Issuance Date”), among the Company and the purchasers (the “Purchasers”)
referred to therein (the “Securities Purchase Agreement”). 
  
 1. EXERCISE OF ADDITIONAL INVESTMENT RIGHT. 
  
 a. Mechanics of Exercise. Subject to the terms and conditions hereof (including, without limitation, the limitations set forth in Section 1(f)), this Additional Investment Right may be exercised by the Holder
on any day, in whole or in part, by (i) delivery of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”), of the Holder’s election to exercise this Additional Investment Right, and (ii)
payment to the Company of an amount equal to the applicable Exercise Price multiplied by the number of Additional Investment Right Shares as to which this Additional Investment Right is being exercised (the “Aggregate Exercise
Price”) in cash or wire transfer of immediately available funds. The date the Exercise Notice and the Aggregate Exercise Price are delivered to the Company (as determined in accordance with the notice provisions hereof) is an
“Exercise Date.” The Holder shall not be required to deliver the original Additional Investment Right in order to effect an exercise hereunder. Execution and delivery of the Exercise Notice with respect to less than all of the
Additional Investment Right Shares shall have the same effect as cancellation of the original Additional Investment Right and issuance of a new Additional Investment Right evidencing the right to purchase the remaining number of Additional
Investment Right Shares. On or before the first Business Day following the Exercise Date, the Company shall transmit by facsimile an acknowledgment of confirmation of receipt of the Exercise Notice and the Aggregate Exercise Price to the Holder and
the Company’s transfer agent (the “Transfer Agent”). On or before the third Business Day following the Exercise Date, the Company shall (X) issue and deliver to the address as specified in the Exercise Notice, a certificate,
registered in the name of the Holder or its designee, for the number of shares of Common Stock to which the Holder is entitled pursuant to such exercise, or (Y) provided that the Transfer Agent is participating in The Depository Trust Company
(“DTC”) Fast Automated Securities Transfer Program, upon the request of the Holder, credit such aggregate number of shares of Common Stock to which the Holder is entitled pursuant to such exercise to the Holder’s or its
designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system. On the Exercise Date, the Holder shall be deemed for all corporate purposes to have become the holder of record of the Additional Investment Right
Shares with respect to which this Additional Investment Right has been exercised, irrespective of the date of delivery of the certificates evidencing such Additional Investment Right Shares. Upon surrender of this Additional Investment Right to the
Company following one or more partial exercises, the Company shall as soon as practicable and in no event later than three (3) Business Days after receipt of the Additional Investment Right and at its own expense, issue a new Additional Investment
Right (in accordance with Section 7(d)) representing the right to purchase the number of Additional Investment Right Shares purchasable immediately prior to such exercise under this Additional Investment Right, less the number of Additional
Investment Right Shares with respect to which this Additional Investment Right is exercised. No fractional shares of Common Stock are to be issued upon the exercise of this Additional Investment Right, but rather the number of shares of Common Stock
to be issued shall be rounded up to the nearest whole number. The Company shall pay any and all taxes which may be payable with respect to the issuance and delivery of Additional Investment Right Shares upon exercise of this Additional Investment
Right. 
  

 - 2 - 

 b. Exercise Price. For purposes of this Additional Investment Right, “Exercise
Price” means $4.40, subject to adjustment as provided herein. 
  
 c. Company’s Failure to Timely Deliver Shares Subject to Section 1(f), if the Company shall fail for any reason or for no reason to issue to the Holder within three (3) Business Days of the Exercise Date, a certificate for the
number of shares of Common Stock to which the Holder is entitled or to credit the Holder’s balance account with DTC for such number of shares of Common Stock to which the Holder is entitled upon the Holder’s exercise of this Additional
Investment Right, the Company shall pay as additional damages in cash to the Holder on each day after such third Business Day that the issuance of such Common Stock is not timely effected an amount equal to 1.5% of the product of (A) the sum of the
number of shares of Common Stock not issued to the Holder on a timely basis and to which the Holder is entitled and (B) the Closing Sale Price of the Common Stock on the Trading Day (as defined in the Securities Purchase Agreement) immediately
preceding the last possible date which the Company could have issued such Common Stock to the Holder without violating Section 1(a). 
  
 d. Absolute and Unconditional Obligation. The Company’s obligations to issue and deliver Additional Investment Right Shares in accordance with
the terms hereof are absolute and unconditional, irrespective of any action or inaction by the holder to enforce the same, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment,
limitation or termination, or any breach or alleged breach by the holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the holder or any other Person. Nothing herein shall limit the
Holder’s right to pursue any other remedies available to it hereunder, at law or in equity, including, without limitation, a decree of specific performance and/or injunctive relief with respect to the Company’s failure to timely deliver
certificates representing Additional Investment Right Shares upon exercise of the Additional Investment Right as required pursuant to the terms hereof. 
  
 e. Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Additional Investment
Right Shares, the Company shall promptly issue to the Holder the number of Additional Investment Right Shares that are not disputed and resolve such dispute in accordance with Section 12. 
  
 f. Limitations on Exercises. The Company shall not effect the exercise of this Additional Investment Right, and no
Person (as defined below) who is the Holder shall have the right to exercise this Additional Investment Right, to the extent that after giving effect to such exercise, such Person (together with such Person’s affiliates) would beneficially own
in excess of 4.99% of the shares of the Common Stock outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of shares of Common Stock beneficially owned by such Person and its
affiliates shall include the number of shares of Common Stock issuable upon exercise of this Additional Investment Right with respect to which the determination of such sentence is being made, but shall exclude shares of Common Stock which would be
issuable upon (i) exercise of the remaining, unexercised portion of this Additional Investment Right beneficially owned by such Person and its affiliates and (ii) exercise 
  

 - 3 - 

 or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such
Person and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the
preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended. For purposes of this Additional Investment Right, in determining the
number of outstanding shares of Common Stock a holder may rely on the number of outstanding shares of Common Stock as reflected in (1) the Company’s most recent Form 10-Q, Form 10-K or other public filing with the Securities and Exchange
Commission, as the case may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or its Transfer Agent setting forth the number of shares of Common Stock outstanding. For any reason at any time, upon the
written or oral request of the Holder, the Company shall within one Business Day confirm orally and in writing to the Holder the number of shares of Common Stock then outstanding. In any case, the number of outstanding shares of Common Stock shall
be determined after giving effect to the conversion or exercise of securities of the Company, including the SPA Additional Investment Rights, by the Holder and its affiliates since the date as of which such number of outstanding shares of Common
Stock was reported. 
  
 2. ADJUSTMENT OF EXERCISE PRICE AND
NUMBER OF ADDITIONAL INVESTMENT RIGHT SHARES. The Exercise Price and the number of Additional Investment Right Shares shall be adjusted from time to time as follows: 
  
 a. Adjustment upon Subdivision or Combination of Common Stock. If the Company at any time after the date of issuance
of this Additional Investment Right subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or more classes of its outstanding shares of Common Stock into a greater number of shares, the Exercise Price in effect
immediately prior to such subdivision will be proportionately reduced and the number of Additional Investment Right Shares will be proportionately increased. If the Company at any time after the date of issuance of this Additional Investment Right
combines (by combination, reverse stock split or otherwise) one or more classes of its outstanding shares of Common Stock into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately
increased and the number of Additional Investment Right Shares will be proportionately decreased. Any adjustment under this Section 2(a) shall become effective at the close of business on the date the subdivision or combination becomes effective.

  
 b. Other Events. If any event occurs of the type
contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of stock appreciation rights, phantom stock rights or other rights with equity features), then the
Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Additional Investment Right Shares so as to protect the rights of the Holder; provided that no such adjustment pursuant to this Section
2(b) will increase the Exercise Price or decrease the number of Additional Investment Right Shares as otherwise determined pursuant to this Section 2. 
  
 3. RIGHTS UPON DISTRIBUTION OF ASSETS. If the Company shall declare or make any dividend or other distribution of its assets (or rights to acquire
its assets) to 
  

 - 4 - 

 holders of Common Stock, by way of return of capital or otherwise (including, without limitation, any distribution of
cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate rearrangement or other similar transaction) (a “Distribution”), at any time after the issuance of this Additional
Investment Right, then, in each such case: 
  
 a. any Exercise
Price in effect immediately prior to the close of business on the record date fixed for the determination of holders of Common Stock entitled to receive the Distribution shall be reduced, effective as of the close of business on such record date, to
a price determined by multiplying such Exercise Price by a fraction of which (i) the numerator shall be the Closing Bid Price of the Common Stock on the Trading Day immediately preceding such record date minus the value of the Distribution (as
determined in good faith by the Company’s Board of Directors) applicable to one share of Common Stock, and (ii) the denominator shall be the Closing Bid Price of the Common Stock on the Trading Day immediately preceding such record date; and

  
 b. the number of Additional Investment Right Shares shall be
increased to a number of shares equal to the number of shares of Common Stock obtainable immediately prior to the close of business on the record date fixed for the determination of holders of Common Stock entitled to receive the Distribution
multiplied by the reciprocal of the fraction set forth in the immediately preceding paragraph (a); provided that in the event that the Distribution is of common stock (“Other Common Stock”) of a company whose common stock is traded
on a national securities exchange or a national automated quotation system, then the Holder may elect to receive a warrant to purchase Other Common Stock in lieu of an increase in the number of Additional Investment Right Shares, the terms of which
shall be identical to those of this Additional Investment Right, except that such warrant shall be exercisable into the number of shares of Other Common Stock that would have been payable to the Holder pursuant to the Distribution had the holder
exercised this Additional Investment Right immediately prior to such record date and with an aggregate exercise price equal to the product of the amount by which the exercise price of this Additional Investment Right was decreased with respect to
the Distribution pursuant to the terms of the immediately preceding paragraph (a) and the number of Additional Investment Right Shares calculated in accordance with the first part of this paragraph (b). 
  
 4. PURCHASE RIGHTS; ORGANIC CHANGE. 
  
 a. Purchase Rights. In addition to any adjustments pursuant to
Section 2 above, if at any time the Company grants, issues or sells any Options, Convertible Securities or rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Common Stock (the
“Purchase Rights”), then the Holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of shares of
Common Stock acquirable upon complete exercise of this Additional Investment Right (without regard to any limitations on the exercise of this Additional Investment Right) immediately before the date on which a record is taken for the grant, issuance
or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Common Stock are to be determined for the grant, issue or sale of such Purchase Rights. 
  

 - 5 - 

 b. Organic Change. Any recapitalization, reorganization, reclassification, consolidation, merger,
sale of all or substantially all of the Company’s assets to another Person or other transaction, in each case which is effected in such a way that holders of Common Stock are entitled to receive securities or assets with respect to or in
exchange for Common Stock is referred to herein as an “Organic Change.” Prior to the consummation of any (i) sale of all or substantially all of the Company’s assets to an acquiring Person or (ii) other Organic Change following
which the Company is not a surviving entity, the Company will secure from the Person purchasing such assets or the Person issuing the securities or providing the assets in such Organic Change (in each case, the “Acquiring Entity”) a
written agreement (in form and substance reasonably satisfactory to the holders of SPA Additional Investment Rights representing at least a majority of the shares of Common Stock obtainable upon exercise of the SPA Additional Investment Rights then
outstanding) to deliver to the Holder in exchange for this Additional Investment Right, a security of the Acquiring Entity evidenced by a written instrument substantially similar in form and substance to this Additional Investment Right and
reasonably satisfactory to the Holder (including, an adjusted exercise price equal to the value for the Common Stock reflected by the terms of such consolidation, merger or sale, and exercisable for a corresponding number of shares of Common Stock
acquirable and receivable upon exercise of this Additional Investment Right (without regard to any limitations on the exercise of this Additional Investment Right), if the value so reflected is less than the Exercise Price in effect immediately
prior to such consolidation, merger or sale). In the event that an Acquiring Entity is directly or indirectly controlled by a company or entity whose common stock or similar equity interest is listed, designated or quoted on a securities exchange or
trading market, the Holder may elect to treat such Person as the Acquiring Entity for purposes of this Section 4(b). Prior to the consummation of any other Organic Change, the Company shall make appropriate provision (in form and substance
reasonably satisfactory to the holders of SPA Additional Investment Rights representing at least a majority of the shares of Common Stock obtainable upon exercise of the SPA Additional Investment Rights then outstanding) to insure that the Holder
thereafter will have the right to acquire and receive in lieu of or in addition to (as the case may be) the shares of Common Stock immediately theretofore acquirable and receivable upon the exercise of this Additional Investment Right (without
regard to any limitations on the exercise of this Additional Investment Right), such shares of stock, securities or assets that would have been issued or payable in such Organic Change with respect to or in exchange for the number of shares of
Common Stock which would have been acquirable and receivable upon the exercise of this Additional Investment Right as of the date of such Organic Change (without regard to any limitations on the exercise of this Additional Investment Right).

  
 5. NONCIRCUMVENTION. The Company hereby covenants and
agrees that the Company will not, by amendment of the Certificate of Incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities, or any other voluntary action, avoid or seek to
avoid the observance or performance of any of the terms of this Additional Investment Right, and will at all times in good faith carry out all the provisions of this Additional Investment Right and take all action as may be required to protect the
rights of the Holder. Without limiting the generality of the foregoing, the Company (i) will not increase the par value of any shares of Common Stock receivable upon the exercise of this Additional Investment Right above the Exercise Price then in
effect, (ii) will take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock upon the exercise of this Additional 
  

 - 6 - 

 Investment Right, and (iii) will, so long as any of the SPA Additional Investment Rights are outstanding, take all action
necessary to reserve and keep available out of its authorized and unissued Common Stock, solely for the purpose of effecting the exercise of the SPA Additional Investment Rights, 100% of the number of shares of Common Stock as shall from time to
time be necessary to effect the exercise of the SPA Additional Investment Rights then outstanding (without regard to any limitations on exercise). 
  
 6. HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s capacity as the
Holder, shall not be entitled to vote or receive dividends or be deemed the holder of shares of Common Stock for any purpose, nor shall anything contained in this Additional Investment Right be construed to confer upon the Holder, solely in such
Person’s capacity as a Holder, any of the rights of a shareholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation,
merger, conveyance or otherwise), receive notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Additional Investment Right Shares which such Person is then entitled to receive upon
the due exercise of this Additional Investment Right. In addition, nothing contained in this Additional Investment Right shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Additional
Investment Right or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company or by creditors of the Company. Notwithstanding this Section 6, the Company will provide the Holder with copies of the same
notices and other information given to the stockholders of the Company generally, contemporaneously with the giving thereof to the stockholders. 
  
 7. REISSUANCE OF ADDITIONAL INVESTMENT RIGHTS. 
  
 a. Transfer of Additional Investment Right. If this Additional Investment Right is to be transferred, the holder shall surrender this Additional
Investment Right to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Additional Investment Right (in accordance with Section 7(d)), registered as the Holder may request, representing the right to
purchase the number of Additional Investment Right Shares being transferred by the Holder and, if less then the total number of Additional Investment Right Shares then underlying this Additional Investment Right is being transferred, a new
Additional Investment Right (in accordance with Section 7(d)) to the Holder representing the right to purchase the number of Additional Investment Right Shares not being transferred. 
  
 b. Lost, Stolen or Mutilated Additional Investment Right. Upon receipt by the Company of evidence reasonably
satisfactory to the Company of the loss, theft, destruction or mutilation of this Additional Investment Right, and, in the case of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in customary form and, in
the case of mutilation, upon surrender and cancellation of this Additional Investment Right, the Company shall execute and deliver to the Holder a new Additional Investment Right (in accordance with Section 7(d)) representing the right to purchase
the Additional Investment Right Shares then underlying this Additional Investment Right. 
  

 - 7 - 

 c. Additional Investment Right Exchangeable for Multiple Additional Investment Rights. This
Additional Investment Right is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Additional Investment Right or Additional Investment Rights (in accordance with Section 7(d)) representing in the
aggregate the right to purchase the number of Additional Investment Right Shares then underlying this Additional Investment Right, and each such new Additional Investment Right will represent the right to purchase such portion of such Additional
Investment Right Shares as is designated by the Holder at the time of such surrender; provided, however, that no Additional Investment Rights for fractional shares of Common Stock shall be given. 
  
 d. Issuance of New Additional Investment Rights. Whenever the Company
is required to issue a new Additional Investment Right pursuant to the terms of this Additional Investment Right, such new Additional Investment Right (i) shall be of like tenor with this Additional Investment Right, (ii) shall represent, as
indicated on the face of such new Additional Investment Right, the right to purchase the Additional Investment Right Shares then underlying this Additional Investment Right (or in the case of a new Additional Investment Right being issued pursuant
to Section 7(a) or Section 7(c), the Additional Investment Right Shares designated by the Holder which, when added to the number of shares of Common Stock underlying the other new Additional Investment Rights issued in connection with such issuance,
does not exceed the number of Additional Investment Right Shares then underlying this Additional Investment Right), (iii) shall have an issuance date, as indicated on the face of such new Additional Investment Right which is the same as the Issuance
Date, and (iv) shall have the same rights and conditions as this Additional Investment Right. 
  
 8. NOTICES. Whenever notice is required to be given under this Additional Investment Right, unless otherwise provided herein, such notice shall be given in accordance with Section 9(f) of the Securities
Purchase Agreement. The Company shall provide the Holder with prompt written notice of all actions taken pursuant to this Additional Investment Right, including in reasonable detail a description of such action and the reason therefore. Without
limiting the generality of the foregoing, the Company will give written notice to the Holder (i) immediately upon any adjustment of the Exercise Price, setting forth in reasonable detail, and certifying, the calculation of such adjustment and (ii)
at least fifteen days prior to the date on which the Company closes its books or takes a record (A) with respect to any dividend or distribution upon the Common Stock, (B) with respect to any grants, issues or sales of any Options, Convertible
Securities or rights to purchase stock, warrants, securities or other property pro rata to holders of Common Stock or (C) for determining rights to vote with respect to any Organic Change, dissolution or liquidation, provided in each case that such
information shall be made known to the public prior to or in conjunction with such notice being provided to the Holder. 
  
 9. AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of this Additional Investment Right may be amended and the Company may
take any action herein prohibited, or omit to perform any act herein required to be performed by it, only if the Company has obtained the written consent of the holders of SPA Additional Investment Rights representing at least a majority of the
shares of Common Stock obtainable upon exercise of the SPA Additional Investment Rights then outstanding; provided that no such action may increase the exercise price of any SPA Additional Investment Right or 
  

 - 8 - 

 decrease the number of shares or class of stock obtainable upon exercise of any SPA Additional Investment Right without
the written consent of the holder of this Additional Investment Right. No such amendment shall be effective to the extent that it applies to less than all of the holders of the SPA Additional Investment Rights then outstanding. 
  
 10. GOVERNING LAW. This Additional Investment Right shall be construed
and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Additional Investment Right shall be governed by, the internal laws of the State of New York, without giving effect to
any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. 
  
 11. CONSTRUCTION; HEADINGS. This Additional Investment Right shall be
deemed to be jointly drafted by the Company and all the Purchasers and shall not be construed against any person as the drafter hereof. The headings of this Additional Investment Right are for convenience of reference and shall not form part of, or
affect the interpretation of, this Additional Investment Right. 
  
 12. DISPUTE RESOLUTION. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Additional Investment Right Shares, the Company shall submit the disputed determinations or
arithmetic calculations via facsimile within two Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation
of the Exercise Price or the Additional Investment Right Shares within three Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two Business Days submit via facsimile
(a) the disputed determination of the Exercise Price to an independent, reputable investment bank selected by the Company and approved by the Holder or (b) the disputed arithmetic calculation of the Additional Investment Right Shares to the
Company’s independent, outside accountant. The Company shall cause at its expense the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no
later than ten Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent
demonstrable error. 
  
 13. REMEDIES, OTHER OBLIGATIONS,
BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Additional Investment Right shall be cumulative and in addition to all other remedies available under this Additional Investment Right, the Securities Purchase Agreement and the
Registration Rights Agreement, at law or in equity (including a decree of specific performance and/or other injunctive relief), and nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply
with the terms of this Additional Investment Right. The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Holder and that the remedy at law for any such breach may be inadequate. The Company
therefore agrees that, in the event of any such breach or threatened breach, the Holder shall be entitled, in addition to all other available remedies, to an injunction restraining any breach, without the necessity of showing economic loss and
without any bond or other security being required. 
  

 - 9 - 

 14. TRANSFER. This Additional Investment Right may not be offered for sale, sold, transferred or
assigned unless (i) the Holder obtains the consent of the Company (not to be unreasonably withheld or delayed) or (ii) the transferee is an affiliate (within the meaning of Rule 405 promulgated under the Securities Act of 1933, as amended) of the
Holder, provided that in each case the transferee is, and upon exercise of this Additional Investment Right will be, an “accredited investor” within the meaning of Rule 501(a) promulgated under such Act. 
  
 15. CERTAIN DEFINITIONS. For purposes of this Additional Investment
Right, the following terms shall have the following meanings: 
  
 a. “Bloomberg” means Bloomberg Financial Markets. 
  
 b. “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in The City of New York or the city of Deerfield Beach, Florida are authorized or required by law to
remain closed. 
  
 c. “Closing Bid Price” and
“Closing Sale Price” means, for any security as of any date, the last closing bid price and last closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market
begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade price, as the case may be, then the last bid price or last trade price, respectively, of such security prior to 4:00:00 p.m., New York
Time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security, the last closing bid price or last trade price, respectively, of such security on the principal securities
exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the
electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any
market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the National Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date
on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price, as the case may be, of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are
unable to agree upon the fair market value of such security, then such dispute shall be resolved pursuant to Section 12. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar
transaction during the applicable calculation period. 
  
 d.
“Common Stock” means (i) the Company’s common stock, par value $.001 per share, and (ii) any capital stock into which such Common Stock shall have been changed or any capital stock resulting from a reclassification of such
Common Stock. 
  

 - 10 - 

 e. “Convertible Securities” means any stock or securities (other than Options) directly
or indirectly convertible into or exercisable or exchangeable for Common Stock. 
  
 f. “Effective Date” means the date on which the Registration Statement (as defined in the Registration Rights Agreement) is first declared effective by the SEC. 
  
 g. “Expiration Date” means the date that is 90 calendar days
following, but not including, the Effective Date (or, if the 90th calendar day is not a Trading Day, the next
succeeding Trading Day); provided, however, if, at any time after the Effective Date and prior to the original Expiration Date the Registration Statement is not effective and available for the resale of all of the Registrable Securities (as defined
in the Registration Rights Agreement) (including during an Allowable Grace Period (as defined in the Registration Rights Agreement)), such original Expiration Date shall automatically be extended by such number of days after the Effective Date and
prior to the original Expiration Date that the Registration Statement was not effective and available for the resale of all of the Registrable Securities. 
  
 h. “Options” means any rights, warrants or options to subscribe for or purchase Common Stock or Convertible Securities. 
  
 i. “Person” means an individual, a limited liability
company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other entity and a government or any department or agency thereof. 
  
 j. “Principal Market” means the Nasdaq SmallCap Market. 
  
 k. “Registration Rights Agreement” means that certain
registration rights agreement dated the Initial Issuance Date by and among the Company and the Purchasers. 
  
 l. “Trading Day” means any day on which the Common Stock is traded on the Principal Market, or, if the Principal Market is not the
principal trading market for the Common Stock, then on the principal securities exchange or securities market on which the Common Stock is then traded; provided that “Trading Day” shall not include any day on which the Common Stock is
scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Common Stock is suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not designate in advance
the closing time of trading on such exchange or market, then during the hour ending at 4:00 p.m., New York City Time). 
  
 [Signature Page Follows] 
  

 - 11 - 

 IN WITNESS WHEREOF, the Company has caused this Additional Investment Right to be duly executed as
of the Issuance Date set out above. 
  

			
	EDIETS.COM, INC.
		
	 By:
	 	  

	 Name:
 Title:
	 	 

  

 EXHIBIT A 
  

EXERCISE NOTICE 
  
 TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS 
 ADDITIONAL INVESTMENT RIGHT 
  
 EDIETS.COM, INC. 
  
 To: eDiets.com, Inc. 
  
 The undersigned is the holder of Additional Investment Right No.
             (the “Additional Investment Right”) issued by eDiets.com, Inc., a Delaware corporation (the “Company”). Capitalized terms used herein
and not otherwise defined shall have the respective meanings set forth in the Additional Investment Right. 
  
 1. The Additional Investment Right is currently exercisable to purchase a total of
             Additional Investment Right Shares. 
  
 2. The undersigned holder hereby exercises its right to purchase
                 Additional Investment Right Shares pursuant to the Additional Investment Right. 
  
 3. The holder shall pay the sum of
$                 to the Company in accordance with the terms of the Additional Investment Right. 
  
 4. Pursuant to this exercise, the Company shall deliver to the holder
                 Additional Investment Right Shares in accordance with the terms of the Additional Investment Right. 
  
 5. Following this exercise, the Additional Investment Right shall be
exercisable to purchase a total of                      Additional Investment Right Shares. 
  
 6. The undersigned hereby confirms to the Company that it is an
“accredited investor” within the meaning of Rule 501(a) promulgated under the Securities Act of 1933, as amended. 
  
 Please issue the Additional Investment Right Shares in the following name and to the following address: 
  
 Issue
to:                                       
                                        
                                        
                                        
                                  
                                       
                                        
                                        
                                        
                                        

                                       
                                        
                                        
                                        
                                        

  
 Account
Number:                                       
                                        
                                        
                                        
               
 (if electronic book entry transfer)

  
 DTC Participant
Number:                                       
                                        
                                        
                                        

(if electronic book entry transfer) 

			
	Date:	 	                         ,
            
	
	  

	Name of Registered Holder
		
	By:	 	  

	 Name:
 Title:
	 	 

 ACKNOWLEDGMENT 
  
 The Company hereby acknowledges this Exercise Notice and hereby directs [Transfer Agent] to issue the above indicated number
of shares of Common Stock in accordance with the Transfer Agent Instructions dated April         , 2004 from the Company and acknowledged and agreed to by [Transfer Agent]. 
  

			
	EDIETS.COM, INC.
		
	By:	 	  

	 Name:
 Title:
	 	 

 FORM OF ASSIGNMENT 
  
 [To be completed and signed only upon transfer of Additional Investment Right] 
  
 FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto
                         the right represented by the within Additional Investment Right to purchase
             shares of Common Stock of eDiets.com, Inc. to which the within Additional Investment Right relates and appoints
                     attorney to transfer said right on the books of eDiets.com, Inc. with full power of substitution in the premises.

  
 Dated:
                    ,          
  

	
	  

	(Signature must conform in all respects to name of holder as specified on the face of the Additional Investment Right)
	  

	Address of Transferee
	  

	  

  
 In the presence of:Employment Agreement With Wayne R. Holbrook

 Exhibit 10.6 
  
 Employment Agreement with Wayne R. Holbrook 

 EMPLOYMENT AGREEMENT – Wayne R. Holbrook 
  
 THIS EMPLOYMENT AGREEMENT (the “Agreement”) is made by and between Royal BodyCare,
Inc. (“Employer”) located at 2301 Crown Court, Irving, Texas 75038 and Wayne R. Holbrook (“Employee”), residing at 3809 Fox Glen Dr., Irving, Texas 75062. 
  
 The parties to this Agreement declare that: 
  
 The Employer is engaged in, among other businesses, the international distribution of nutritional supplements and personal care products through the network marketing
distribution model, and the distribution of wound care and oncology care products. 
  
 The Employee is willing to be employed by the Employer, and the Employer is willing to employ the Employee, on the terms, covenants, and conditions set forth in this Agreement. 
  
 In consideration of the mutual promises set forth in this Agreement, the Employer and the Employee agree as follows: 
  
 Section 1. Effective Date. The Effective Date of this Agreement shall be
January 1, 2004. 
  
 Section 2. Employment Title and Duties. The
Employer shall employ the Employee in the capacity of President. In this capacity, Employee shall have the responsibility to perform all duties that are customarily performed by one holding that position in other, same, or similar businesses or
enterprises as that engaged by Employer. The Employee’s shall be responsible for the Employer’s network marketing business and operations conducted in the US, Canada and all other international territories, whether operations are conducted
through a license agreement, or through an entity owned by or affiliated with the Employer. The Employee shall not be responsible for the Employer’s manufacturing operations, research and development operations, or the business or operations of
MPM Medical, Inc. A diagram of the Employee’s functional responsibility is attached as Exhibit A. The Employee accepts this employment, subject to the general supervision and pursuant to the orders and direction of the Employer. The Employee
shall also render such other and unrelated services and duties as may be assigned from time to time by the Employer. 
  
 Section 3. Compensation of the Employee. The Employer shall pay the Employee in full payment for the Employee’s services under this Agreement, the
following compensation: 
  

	 	a.	Annual Base Salary. Employee’s annual base salary shall be Two Hundred Fifty Thousand Dollars ($250,000) per year payable bi-weekly in twenty-six (26) equal
payments. 

  

	 	b.	Incentive Bonus. Employee shall be paid a cash incentive bonus as described in Exhibit B. 

  

	 	c.	Uniform Benefits. Employee shall receive uniform benefits as set forth in Employer’s manual for executive employees, such benefits to include but not be limited
to personal time off, holidays, retirement benefits and health insurance benefits. EMPLOYER RESERVES THE RIGHT UNILATERALLY TO AMEND ANY AND ALL PARTS OF THE EMPLOYER’S MANUAL FOR EXECUTIVE EMPLOYEES AT ITS SOLE DISCRETION.

 Employment Agreement – Wayne R. Holbrook 
 Page 2 
  

 Section 4. Best Efforts of the Employee. The Employee agrees to perform all of the duties pursuant to
the express and implicit terms of this Agreement to the reasonable satisfaction of the Employer. The Employee further agrees to perform such duties faithfully and to the best of his ability, talent, and experience. 
  
 Section 5. Place of Employment. The Employee shall render such duties at 2301
Crown Court, Irving, Texas 75038 and at such other places as the Employer shall in good faith require or as the interest, needs, business, or opportunity of the Employer shall require. 
  
 Section 6. Non-Competition with the Employer during the Term of Employment. The Employee shall devote all his time, attention,
knowledge, and skills solely to the business and interest of the Employer, and the Employer shall be entitled to all of the benefits and profits arising from the work of the Employee. The Employee shall not, during the term of this Agreement, be
interested directly or indirectly, in any manner, as partner, officer, director, shareholder, advisor, employee, or in any other capacity in any other business similar to the Employer’s business or any allied trade. However, nothing contained
in this section shall prevent or limit the right of the Employee from investing in the capital stock or other securities of any corporation whose stock or securities are publicly owned and traded on any public exchange, nor shall anything contained
in this section prevent or limit the Employee from investing in real estate. 
  
 Section 7. Restrictions on the Use of Trade Secrets and Records. During the term of employment under this Agreement, the Employee may have access to various trade secrets, consisting of formulas, patterns, devices, inventions,
processes, and compilations of information, records and specifications, all of which are owned by the Employer and regularly used in the operation of the Employer’s business. All files, records, customer lists, documents, drawings,
specifications, equipment, and similar items relating to the business of the Employer, whether they are prepared by the Employee or come into the Employee’s possession in any other way and whether or not they contain or constitute trade secrets
owned by the Employer, are and shall remain the exclusive property of the Employer and shall not be removed from the premises of the Employer under any circumstances whatsoever without the prior written consent of the Employer. The Employee agrees
not to divulge, misappropriate, or disclose any of these trade secrets and records directly or indirectly, to any person, firm, corporation, or other entity in any manner whatsoever, either during the term of this Agreement or at any time thereafter
except as required in the course of employment. 
  
 Section 8. Term.
This Agreement shall be effective for period of four (4) years beginning on January 1, 2004 and ending on December 31, 2007. This Agreement shall be automatically renewed for an additional one-year period upon expiration of its initial term and each
anniversary thereafter, unless terminated by either Employer or Employee upon thirty (30) days prior written notice to the other. 
  
  

 Employment Agreement – Wayne R. Holbrook 
 Page 3 
  

 Section 9. Termination. 
  

	 	a.	Definition. For purposes of this Section 9, “Change of Control” shall be defined as follows: 

  
 (i) any “person” (as such term is used in Sections 13(d) and
14(d) of the Exchange Act), other than Employer’s current Chief Executive Officer, Clinton H. Howard, becomes the “beneficial owner” (as defined in Rule 13d-3 under the Exchange Act), directly or indirectly, of securities of Employer
representing fifty percent (50%) or more of the combined voting power of Employer’s then outstanding securities; 
  
 (ii) as a result of, or in connection with, any tender offer or exchange offer, merger, or other business combination (a “Transaction”), the
persons who were directors of Employer immediately before the Transaction shall cease to constitute a majority of the Board of Directors of Employer or any successor to Employer; 
  
 (iii) Employer is reorganized, merged or consolidated with another corporation and as a result of the reorganization,
merger or consolidation less than fifty percent (50%) of the outstanding voting securities of the surviving or resulting corporation shall then be owned in the aggregate by the former stockholders of Employer; 
  
 (iv) Employer sells or disposes of all or substantially all of its assets
to any person, other corporation, or other legal entity not controlled by Employer, or the shareholders approve a plan of complete liquidation or an agreement for the sale or disposition of Employer in a majority; or, 
  
 (v) another event occurs that the Board deems to be a change in the control
of Employer. 
  

	 	b.	Non-renewal by Employer. If the Employer elects to terminate this Agreement pursuant to the terms of Section 8, the Employee, if requested by the Employer, shall
continue to render services, and shall be paid compensation as provided in this Agreement up to the date of termination, and shall be entitled to receive payment for accrued, unused personal time off as provided in the Employer’s manual for
executive employees. In addition, the Employee shall continue to be paid his base salary for a period of six (6) months following the date of termination, less all amounts required to be held and deducted. 

  

	 	c.	Non-renewal by Employee. If the Employee elects to terminate this Agreement pursuant to the terms of Section 8, the Employee shall continue to render services and
shall be paid compensation as provided in this Agreement up to the date of termination. In addition, Employee shall be entitled to receive payment for accrued, unused personal time off as provided in the Employer’s manual for executive
employees. 

  

	 	d.	Cause. If the Employee willfully breaches or habitually neglects the performance of duties required under the terms of this Agreement (“Cause”), the Employer
may terminate this Agreement by giving written notice of termination to the Employee without prejudice to any other remedy to which the Employer may be entitled either at law, in equity, or under this Agreement. In this case, Employee shall be paid
compensation as provided in this Agreement up to the date of termination, and shall be entitled to receive payment for accrued, unused personal time off as provided in the Employer’s manual for executive employees. 

  

 Employment Agreement – Wayne R. Holbrook 
 Page 4 
  

	 	e.	Good Reason. If the Employer willfully breaches any material term of this Agreement, or in the event of a Change of Control (collectively “Good Reason”),
Employee may terminate this Agreement by giving written notice of termination to the Employer without prejudice to any other remedy to which the Employee may be entitled either at law, in equity, or under this Agreement. In this case, Employee shall
be paid compensation as provided in this Agreement up to the end of the initial term or renewal term in effect, and shall be entitled to receive payment for accrued, unused personal time off as provided in the Employer’s manual for executive
employees. In addition, the Employee shall continue to be paid his base salary for a period of six (6) months following the date of termination, less all amounts required to be held and deducted. 

  

	 	f.	Death. This Agreement shall be deemed terminated as of the date of Employee’s death. In this case, the Employer shall pay compensation as provided in this
Agreement up to the date of termination. In addition, the Employer shall be obligated to pay Employee’s accrued, unused personal time off as provided for terminating employee’s in the Employer’s manual for executive employees.

  

	 	g.	Disability. Should the Employee be unable to perform his duties under this Agreement by reason of disability for a period of ninety (90) days, Employer shall have the
right to terminate this Agreement upon written notice to Employee. During the period that Employee fails to perform his duties as a result of disability, the Employee shall continue to receive compensation as provided by this Agreement to the extent
Employee has accrued, unused personal time off available. Should Employee exhaust accrued, unused personal time off prior to a date six (6) months following the date on which Employee was determined to be disabled, Employer will continue to pay the
Employee 50% of the Employee’s base compensation until the sooner of (i) the date on which Employee begins to receive disability benefits under a long-term disability insurance policy provided to Employee by or through Employer, or (ii) the
date that is six (6) months after the date on which Employee was determined to be disabled. It is the intent of the parties hereto that, in the event Employee is disabled, Employer’s maximum obligation for payment of accrued, unused personal
time off is a period of six (6) months. 

  

	 	h.	Early Termination by Employer. Should Employer terminate this Agreement prior to the end of the initial term or any renewal term in effect, other than by reason of
Cause, death or disability, whether or not such termination is in connection with or as a result of a Change of Control, Employee shall be paid compensation as provided in this Agreement up to the end of the initial term or renewal term in effect,
and shall be entitled to receive payment for accrued, unused personal time off as provided in the Employer’s manual for executive employees. In addition, the Employee shall continue to be paid his base salary for a period of six (6) months
following the date of termination, less all amounts required to be held and deducted. 

  

	 	i.	Early Termination by Employee. Should Employee terminate this Agreement prior to the end of the initial term or any renewal term in effect, other than for Good Reason,
death or disability, Employee shall be paid compensation as provided in this Agreement up to the date of termination, but shall not be entitled to receive payment for any accrued, unused personal time off, notwithstanding the provisions of the
Employer’s manual for executive employees. 

  

 Employment Agreement – Wayne R. Holbrook 
 Page 5 
  

 Section 10. Indemnity. The Employer shall indemnify the Employee and hold the Employee harmless for any
acts or decisions made by the Employee in good faith while performing services for the Employer and will use its best efforts, as may reasonably be required, to maintain coverage in the amount of $1,000,000 for the Employee under an insurance policy
covering the officers and directors of the Employer against lawsuits. The Employer shall pay all expenses, including attorney’s fees, actually and necessarily incurred by the Employee in connection with any appeal thereon, including the cost of
court settlements. 
  
 Section 11. Effect of Partial Invalidity. The
invalidity of any portion of this Agreement shall not affect the validity of any other provision. In the event that any provision of this Agreement is held to be invalid, the parties agree that the remaining provisions shall remain in full force and
effect. 
  
 Section 12. Entire Agreement. This Agreement contains
the complete Agreement between the parties and shall supersede all other agreements, either oral or written, between the parties. The parties stipulate that neither of them has made any representations except as are specifically set forth in this
Agreement and each of the parties acknowledges that they have relied on their own judgment in entering into this Agreement. 
  
 Section 13. Assignment. Neither party to this Agreement may assign their rights under this Agreement unless the other party so consents to the assignment in
writing. 
  
 Section 14. Notices. All notices, requests, demands,
and other communications shall be in writing and shall be given by registered or certified mail, postage prepaid, to the addresses shown on the first page of this Agreement, or to such subsequent addresses as the parties shall so designate in
writing. 
  
 Section 15. Arbitration. Any controversy or claim
arising out of this Agreement, or the breach of this Agreement shall be settled by arbitration in accordance with the Commercial Arbitration Rules of the American Arbitration Association, and judgment upon the award rendered by the Arbitrator may be
entered in any court having jurisdiction. 
  
 Section 16. Attorney’s
Fees. If any action at law or in equity, including an action for declaratory relief is brought to enforce or interpret the provisions of this Agreement, the prevailing party will be entitled to reasonable attorney’s fees as determined
by the court in the same action. 
  
 Section 17. Amendment. Any
modification, amendment or change of this Agreement will be effective only if it is in a writing signed by both parties. 
  
 Section 18. Governing Law. This Agreement, and all transactions contemplated by this Agreement, shall be governed by, construed, and enforced in accordance
with the laws of the State of Texas. 
  
 Section 19. Headings. The
titles to the paragraphs of this Agreement are solely for the convenience of the parties and shall not affect in any way the meaning or interpretation of this Agreement. 
  

 Employment Agreement – Wayne R. Holbrook 
 Page 6 
  

 Section 20. MANAGEMENT ORGANIZATION. EMPLOYER, ACTING THROUGH ITS CHIEF EXECUTIVE OFFICER WITH THE
CONCURRENCE OF THE INDEPENDENT MEMBERS OF EMPLOYER’S BOARD OF DIRECTORS, RESERVES THE RIGHT UNILATERALLY TO REVISE THE ORGANIZATION OF ANY AND ALL OF THE MANAGEMENT FUNCTIONS AND RELATED REPORTING RELATIONSHIPS AT ITS SOLE DISCRETION. THE
CONTENTS OF THE DIAGRAM ATTACHED AS EXHIBIT A SHALL BE SUBORDINATE TO THE AUTHORITY OF THE EMPLOYER TO REVISE MANAGEMENT ORGANIZATION AND RELATED REPORTING RELATIONSHIPS AS PROVIDED IN THIS SECTION. 
  
 IN WITNESS WHEREOF, the parties have executed this Agreement on this 20th day of February, 2004. 
  

					
	 EMPLOYEE:
	 	 EMPLOYER:

		
	 	 	 Royal BodyCare, Inc.

			
	 /s/ Wayne R. Holbrook

	 	 By:
	 	 /s/ Clinton H. Howard

	 (Signature)
	 	 	 	 (Signature)

			
	 Wayne R. Holbrook
	 	 	 	 Clinton H. Howard

	 	 	 	 	 Chief Executive Officer

  

 EXHIBIT A 
  

	
	

 EXHIBIT B 
  

CASH INCENTIVE BONUS 
  
 For purposes of this Exhibit B, “Operating Margin” shall be defined as sales minus the sum of cost of goods sold and distributor commissions. Sales, cost of
goods sold and distributor commissions shall be reported each month on the same basis as that used to report the Employer’s results of operations in its audited financial statements, and in accordance with generally accepted accounting
principles. For purposes of this section, “RBC” shall mean the network marketing business conducted in the US, Canada and any other international territory, whether through a license agreement or through an entity owned by the Employer or
affiliated with the Employer, and shall exclude the operations of Employer’s wholly owned subsidiary, MPM Medical, Inc. 
  
 Employee shall be entitled to receive a cash incentive bonus based on the increase in Operating Margin earned by RBC each month. For purposes of this Exhibit, Operating
Margin shall be defined as sales minus the sum of cost of goods sold and distributor commissions. Sales, cost of goods sold and distributor commissions shall be reported each month on the same basis as that used to report the Employer’s results
of operations in its audited financial statements, and in accordance with generally accepted accounting principles. For purposes of this Exhibit, RBC shall mean the network marketing business conducted in the US, Canada and any other international
territory, whether through a license agreement or through an entity owned by the Employer or affiliated with the Employer. The Bonus shall be based on the monthly increase in RBC’s Operating Margin over RBC’s Base Operating Margin, which
is equal to $592,000. For each increment of $84,000 that RBC’s Operating Margin increases over the Base, the Employee shall receive a Bonus of $4,200. Employee shall be paid this Bonus the month following the month in which the bonus is earned.

  
 If the Employee earns a Bonus of $8,400 or more for three consecutive months,
his annual base salary shall be adjusted according to the following calculation, up to a maximum annual rate of $750,000. This adjustment shall be calculated by multiplying by 12, the difference between the lowest Bonus earned during the preceding
three-month period and $4,200. For example, if the Employee earns monthly Bonuses of $8,400, $12,600 and $12,600 in three consecutive months, the Employee’s annual base salary shall be increased by $50,400 ($8,400 - $4,200 = $4,200; $4,200 x 12
= $50,400). If the Employee earns monthly Bonuses of $4,200, $8,400 and $8,400 in three consecutive months, the Employee’s annual base salary shall not be increased ($4,200 - $4,200 = $0; $0 x 12 = $0). For each incremental increase of $50,400
in the Employee’s annual base salary, RBC’s Base Operating Margin shall increase by an increment of $84,000. An increase in the Employee’s annual base salary pursuant to this Exhibit shall become effective the first full pay period of
the second month following the last month in the three consecutive month period that gave rise the to the increase. For example, if an increase in the Employee’s annual base salary is warranted by Bonuses earned for the months of February,
March and April, the increase will become effective during the first full pay period of June. Accordingly, RBC’s Base Operating Margin for the month during which the Employee’s annual base salary is adjusted shall be prorated based on the
number of days paid at the old and new annual base salary rates. 
  
 Not
withstanding any other provisions of this Exhibit, the Employer shall not be obligated to pay the Employee in any month, a rate of base salary plus Bonus that, if annualized, would result in annual compensation exceeding $750,000. 

 If RBC’s Operating Margin is below RBC’s Base Operating Margin, as adjusted pursuant to the previous paragraph,
in any month, the Employee’s annual base salary shall be reduced effective the first full pay period following determination of this result. This reduction shall be calculated as follows: the difference between RBC’s Operating Margin and
the Base Operating Margin shall be divided by $84,000 and rounded up to the next highest whole number; this whole number shall then be multiplied by $50,400. For example, assume RBC’s Operating Margin is $1,400,000 and RBC’s Base Operating
Margin is $1,500,000. In this example, the Employee’s annual base salary would be reduced $100,800 ($1,500,000 - $1,400,000 = $100,000; $100,000 / $84,000 = 1.2; 1.2 is rounded to 2; 2 x $50,400 = $100,800). Accordingly, RBC’s Base
Operating Margin for the month during which the Employee’s annual base salary is adjusted shall be prorated based on the number of days paid at the old and new annual base salary rates. In addition, the Employer shall have the right to deduct
from future Bonus payments, any amounts paid to the Employee as increased annual base salary that were not earned. Notwithstanding any provision of this Exhibit, the Employee’s annual base salary shall in no case be less than $250,000.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00064-of-00352.parquet"}]]